Status:
COMPLETED
Pain Management After Adductor Canal Block for Total Knee Arthroplasty
Lead Sponsor:
Poznan University of Medical Sciences
Conditions:
Knee Osteoarthritis
Knee Arthritis
Eligibility:
All Genders
18-100 years
Phase:
PHASE4
Brief Summary
This randomized, double-blinded, placebo-controlled trial sought to evaluate the efficacy of the iPACK block with Adductor Canal Block on postoperative pain, functional recovery and NLR and PLR levels...
Detailed Description
The Interspace between the popliteal artery and capsule of the posterior knee, or iPACK block, together with the Adductor Canal block (ACB), has been described and shows promise in providing analgesia...
Eligibility Criteria
Inclusion
- Patients \> 18 years old undergoing unilateral total knee arthroplasty
Exclusion
- refusal to participate
- \< 18 yo
- Chronic opioid use
- localized infection
Key Trial Info
Start Date :
June 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 24 2023
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT06086483
Start Date
June 18 2020
End Date
August 24 2023
Last Update
October 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Poznan University of Medical Sciences
Poznan, Poznań, Poland, 61-701